Clinical Trial Update: An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated sleep architecture in patients with bipolar depression treated with ziprasidone and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Affective Disorder Depressive Episode

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Queen's University | Conditions: Depression, Bipolar | Phase 4 | Status: COMPLETED